Literature DB >> 26695096

RhoGDIα Acetylation at K127 and K141 Affects Binding toward Nonprenylated RhoA.

Nora Kuhlmann1, Sarah Wroblowski1, Lukas Scislowski1, Michael Lammers1.   

Abstract

Rho proteins are major regulators of the cytoskeleton. As most Ras-related proteins, they switch between an active, GTP-bound and an inactive, GDP-bound conformation. Rho proteins are targeted to the plasma membrane via a polybasic region and a prenyl group attached to a C-terminal cysteine residue. To distribute Rho proteins in the cell, the molecular chaperone RhoGDIα binds to the prenylated Rho proteins forming a cytosolic pool of mainly GDP-loaded Rho. Most studies characterized the interaction of prenylated Rho proteins and RhoGDIα. However, RhoGDIα was also shown to bind to nonprenylated Rho proteins with physiologically relevant micomolar affinities. Recently, it was discovered that RhoGDIα is targeted by post-translational lysine acetylation. For one site, K141, it was hypothesized that acetylation might lead to increased levels of formation of filamentous actin and filopodia in mammalian cells. The functional consequences of lysine acetylation for the interplay with nonprenylated RhoA have not been investigated. Here, we report that lysine acetylation at lysines K127 and K141 in the RhoGDIα immunoglobulin domain interferes with the interaction toward nonprenylated RhoA using a combined biochemical and biophysical approach. We determined the first crystal structure of a doubly acetylated protein, RhoGDIα, in complex with RhoA·GDP. We discover that the C-terminus of RhoA adopts a different conformation forming an intermolecular β-sheet with the RhoGDIα immunoglobulin domain.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26695096     DOI: 10.1021/acs.biochem.5b01242

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Underappreciated roles for Rho GDP dissociation inhibitors (RhoGDIs) in cell function: Lessons learned from the pancreatic islet β-cell.

Authors:  Anjaneyulu Kowluru; Noah F Gleason
Journal:  Biochem Pharmacol       Date:  2021-12-28       Impact factor: 5.858

Review 2.  RhoA Signaling in Neurodegenerative Diseases.

Authors:  Sissel Ida Schmidt; Morten Blaabjerg; Kristine Freude; Morten Meyer
Journal:  Cells       Date:  2022-05-01       Impact factor: 7.666

3.  Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins.

Authors:  Philipp Knyphausen; Susanne de Boor; Nora Kuhlmann; Lukas Scislowski; Antje Extra; Linda Baldus; Magdalena Schacherl; Ulrich Baumann; Ines Neundorf; Michael Lammers
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

Review 4.  Regulation of RhoA GTPase and novel target proteins for ROCK.

Authors:  Eun-Kyoung Choi; Jae-Gyu Kim; Hee-Jun Kim; Jung-Yoon Cho; Hwalrim Jeong; Yohan Park; Rokibul Islam; Cuong Kim Cap; Jae-Bong Park
Journal:  Small GTPases       Date:  2017-12-03

Review 5.  Regulation of Rho GTPases by RhoGDIs in Human Cancers.

Authors:  Hee Jun Cho; Jong-Tae Kim; Kyoung Eun Baek; Bo-Yeon Kim; Hee Gu Lee
Journal:  Cells       Date:  2019-09-05       Impact factor: 6.600

6.  A proteogenomic portrait of lung squamous cell carcinoma.

Authors:  Shankha Satpathy; Karsten Krug; Pierre M Jean Beltran; Sara R Savage; Francesca Petralia; Chandan Kumar-Sinha; Yongchao Dou; Boris Reva; M Harry Kane; Shayan C Avanessian; Suhas V Vasaikar; Azra Krek; Jonathan T Lei; Eric J Jaehnig; Tatiana Omelchenko; Yifat Geffen; Erik J Bergstrom; Vasileios Stathias; Karen E Christianson; David I Heiman; Marcin P Cieslik; Song Cao; Xiaoyu Song; Jiayi Ji; Wenke Liu; Kai Li; Bo Wen; Yize Li; Zeynep H Gümüş; Myvizhi Esai Selvan; Rama Soundararajan; Tanvi H Visal; Maria G Raso; Edwin Roger Parra; Özgün Babur; Pankaj Vats; Shankara Anand; Tobias Schraink; MacIntosh Cornwell; Fernanda Martins Rodrigues; Houxiang Zhu; Chia-Kuei Mo; Yuping Zhang; Felipe da Veiga Leprevost; Chen Huang; Arul M Chinnaiyan; Matthew A Wyczalkowski; Gilbert S Omenn; Chelsea J Newton; Stephan Schurer; Kelly V Ruggles; David Fenyö; Scott D Jewell; Mathangi Thiagarajan; Mehdi Mesri; Henry Rodriguez; Sendurai A Mani; Namrata D Udeshi; Gad Getz; James Suh; Qing Kay Li; Galen Hostetter; Paul K Paik; Saravana M Dhanasekaran; Ramaswamy Govindan; Li Ding; Ana I Robles; Karl R Clauser; Alexey I Nesvizhskii; Pei Wang; Steven A Carr; Bing Zhang; D R Mani; Michael A Gillette
Journal:  Cell       Date:  2021-08-05       Impact factor: 66.850

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.